Efficacy and safety of lurasidone in bipolar depression: results from two, double blind, placebo-controlled studies

被引：0
|
作者：
Loebel, A. [1 ]
Cucchiaro, J. [1 ]
Silva, R. [1 ]
Sarma, K. [1 ]
Kroger, H. [1 ]
Calabrese, J. [2 ]
Sachs, G. [3 ,4 ]
Grossman, F. [1 ]
Pikalov, A. [1 ]
机构：
[1] Sunov Pharmaceut Inc, Clin Dev, Ft Lee, NJ USA
[2] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA
[3] Massachusetts Gen Hosp, Bipolar Clin, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Res Program, Boston, MA 02114 USA
来源：
BIPOLAR DISORDERS | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：131 / 132
页数：2
相关论文
共 50 条
  • [21] OMALIZUMAB EFFICACY AND SAFETY IN NASAL POLYPOSIS: RESULTS FROM TWO PARALLEL, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS
    Gevaert, P.
    Bachert, C.
    Corren, J.
    Mullol, J.
    Han, J.
    Ow, R.
    Islam, L.
    Howard, M.
    Owen, R.
    Wong, K.
    Kaufman, D.
    Omachi, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S17 - S17
  • [22] Quetiapine for the treatment of bipolar II depression: Analysis of data from two randomized, double-blind, placebo-controlled studies
    Suppes, Trisha
    Hirschfeld, Robert M.
    Vieta, Eduard
    Raines, Shane
    Paulsson, Bjorn
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2008, 9 (03): : 198 - 211
  • [23] Double-blind, placebo-controlled study of quetiapine in bipolar depression
    Calabrese, JR
    Macfadden, W
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S92 - S92
  • [24] Quetiapine monotherapy for bipolar II depression: Pooled results from two placebo-controlled studies
    Hirschfeld, R.
    Suppes, T.
    Vieta, E.
    Carlsson, A.
    Stening, G.
    Macfadden, W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S237 - S237
  • [25] Double-blind, placebo-controlled trial of pioglitazone for bipolar depression
    Aftab, Awais
    Kemp, David E.
    Ganocy, Stephen J.
    Schinagle, Martha
    Conroy, Carla
    Brownrigg, Brittany
    D'Arcangelo, Nicole
    Goto, Toyomi
    Woods, Nicole
    Serrano, Mary Beth
    Han, Huiqin
    Calabrese, Joseph R.
    Gao, Keming
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 245 : 957 - 964
  • [26] Double-blind, placebo-controlled study of quetiapine in bipolar depression
    Calabrese, JR
    Macfadden, W
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S299 - S300
  • [27] Double-blind, placebo-controlled study of quetiapine in bipolar depression
    Calabrese, J
    Macfadden, W
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : A16 - A16
  • [28] Double-blind, placebo-controlled study of quetiapine in bipolar depression
    Calabrese, JR
    Macfadden, W
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S330 - S331
  • [29] Double-blind, placebo-controlled study of quetiapine in bipolar depression
    Calabrese, JR
    Macfadden, W
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    ACTA PSYCHIATRICA SCANDINAVICA, 2004, 110 : 29 - 30
  • [30] EFFICACY OF LOW DOSE LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Kane, John M.
    Silva, Robert
    Goldman, Robert
    Watabe, Kei
    Cucchiaro, Josephine
    Loebel, Antony
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S317 - S317
12345